MP67-02 INCREASED HP1-GAMMA EXPRESSION ASSOCIATES WITH ADVERSE OUTCOME IN PATIENTS WITH NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA

Yu Zhu,Zewei Wang,Dingwei Ye
DOI: https://doi.org/10.1016/j.juro.2017.02.2038
2017-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging II1 Apr 2017MP67-02 INCREASED HP1-GAMMA EXPRESSION ASSOCIATES WITH ADVERSE OUTCOME IN PATIENTS WITH NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA Yu Zhu, Zewei Wang, and Dingwei Ye Yu ZhuYu Zhu More articles by this author , Zewei WangZewei Wang More articles by this author , and Dingwei YeDingwei Ye More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.2038AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Heterochromatin protein 1 gamma (HP1?) is a non-histone heterochromatic protein, which plays an important role in maintaining the stability of chromatin and embryonic development. Recently, HP1? has been implied to be involved in the development and progression of cancer. Here, we investgated the association of HP1? expression with oncologic outcome of patients with non-metastatic clear cell renal cell carcinoma (ccRCC). METHODS In this retrospective study, we enrolled 721 patients with non-metastatic ccRCC performed partial or radical nephrectomy at two academic medical centers between 2005 and 2009. The first cohort with 521 patients was treated as training cohort and the other as validation cohort. Tissue microarrays (TMAs) were built on triplicate from formalin-fixed, paraffin embedded specimens. Immunohistochemistry (IHC) was performed and the association of HP1? expression with standard pathologic features and clinical outcomes were evaluated. RESULTS High HP1? expression were remarkably correlated with shortened survival time (P = 0.001 and P < 0.001, respectively) and increased risk of recurrence (P = 0.037 and P = 0.001, respectively) in both cohorts. HP1? could also offer a better prognostic stratification based on traditional histologic factors. Furthermore, multivariate analyses confirmed HP1? to be an independent adverse prognostic factor for post-operative survival of patients. A predictive nomogram was generated based on identified independent risk factors to for a better prognosis of patients’ survival at 5 and 10 years. CONCLUSIONS HP1? expression emerges as an independent prognostic factor for non-metastatic ccRCC patients after surgical treatment © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e871 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Yu Zhu More articles by this author Zewei Wang More articles by this author Dingwei Ye More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?